BridgeBio Pharma (BBIO) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1
-0.74
-0.47
-0.2

Details

Expected EPS
-1.003318
Actual EPS
-0.86
Surprise EPS
0.14
Surprise Percent
+14.28%

Description

BridgeBio Pharma (BBIO) has reported earnings of -0.86 per share for Q4 2024.

0 Comments

Share your thoughts